tiprankstipranks
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines treatment of pancreatic cancer granted orphan status
The FlyBeOne Medicines treatment of pancreatic cancer granted orphan status
2d ago
ONC
BeOne Medicines Grants New RSUs to 215 Employees Under 2016 Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants New RSUs to 215 Employees Under 2016 Incentive Plan
3d ago
6160
BeOne Medicines price target raised to $416 from $413 at Truist
PremiumThe Fly
BeOne Medicines price target raised to $416 from $413 at Truist
4d ago
ONC
BeOne Medicines price target raised to $451 from $436 at RBC Capital
PremiumThe Fly
BeOne Medicines price target raised to $451 from $436 at RBC Capital
4d ago
ONC
BeOne Medicines’ BRUKINSA Delivers Pivotal Phase 3 Win in Frontline Mantle Cell Lymphoma
PremiumCompany Announcements
BeOne Medicines’ BRUKINSA Delivers Pivotal Phase 3 Win in Frontline Mantle Cell Lymphoma
11d ago
6160
BeOne Medicines’ Brukinsa shows efficacy in Phase 3 lymphoma trial
PremiumThe FlyBeOne Medicines’ Brukinsa shows efficacy in Phase 3 lymphoma trial
11d ago
ONC
BeOne Medicines Faces RMB446 Million Tax Payment in China, Sees No Material Impact
Premium
Company Announcements
BeOne Medicines Faces RMB446 Million Tax Payment in China, Sees No Material Impact
15d ago
6160
BeOne Medicines Grants New Equity Awards Under 2016 Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants New Equity Awards Under 2016 Incentive Plan
23d ago
6160
BeOne Medicines Files U.S. Form S-8 to Expand Equity Incentive Plans
PremiumCompany Announcements
BeOne Medicines Files U.S. Form S-8 to Expand Equity Incentive Plans
29d ago
6160
BeOne Medicines Shareholders Approve All AGM Resolutions and Refresh Board
PremiumCompany Announcements
BeOne Medicines Shareholders Approve All AGM Resolutions and Refresh Board
29d ago
6160
BeOne Medicines Sets Out Board and Committee Structure to Bolster Governance
PremiumCompany Announcements
BeOne Medicines Sets Out Board and Committee Structure to Bolster Governance
29d ago
6160
BeOne Medicines announces presentation of Phase 3 data in CLL patients
PremiumThe Fly
BeOne Medicines announces presentation of Phase 3 data in CLL patients
30d ago
ONC
BeOne Medicines Secures Multiple HKEX Rule Waivers to Support Flexible Financing and Partnerships
PremiumCompany AnnouncementsBeOne Medicines Secures Multiple HKEX Rule Waivers to Support Flexible Financing and Partnerships
30d ago
6160
BeOne Medicines Formalizes Compensation Committee Charter to Strengthen Governance
Premium
Company Announcements
BeOne Medicines Formalizes Compensation Committee Charter to Strengthen Governance
30d ago
6160
BeOne Medicines Grants RSUs to 381 Employees Under Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants RSUs to 381 Employees Under Incentive Plan
1M ago
6160
BeOne Medicines price target raised to $436 from $425 at RBC Capital
PremiumThe Fly
BeOne Medicines price target raised to $436 from $425 at RBC Capital
1M ago
ONC
BeOne Medicines’ combination shows improved survival in adenocarcinoma
PremiumThe Fly
BeOne Medicines’ combination shows improved survival in adenocarcinoma
1M ago
ONC
BeOne Medicines price target raised to $367 from $364 at Leerink
PremiumThe Fly
BeOne Medicines price target raised to $367 from $364 at Leerink
2M ago
ONC
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
PremiumCompany Announcements
BeOne Wins First-in-Class U.S. FDA Nod for BCL2 Drug in Relapsed Mantle Cell Lymphoma
2M ago
6160
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
PremiumThe FlyBeOne Medicines’ Beqalzi granted accelerated approval by FDA
2M ago
ONC
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants New RSUs to 201 Employees Under Equity Incentive Plan
2M ago
6160
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
Premium
The Fly
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
2M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >